Meg Spencer, Chairman of the Board. Meg Spencer is CEO and President of Hamilton Biovet, Inc., a supplier of large and small animal breeding, diagnostic and therapeutic products and was a co-founder and former CEO of Hamilton Thorne. Ms. Spencer has prior experience in the field of regenerative medicine and other technology markets having founded two previous companies, taking each from start-up to global market leadership in their respective sectors.
Diarmaid H. Douglas-Hamilton, Director, Corporate Secretary, Chief Technology Officer - Mr. Douglas-Hamilton is a co-founder, Chief Technology Officer and Senior Vice-President Research & Development of Hamilton Thorne Inc. and a Director and Chief Technology Officer of Hamilton Thorne, Ltd. He was formerly Principal Scientist and Project Director at Avco Everett Laboratories, and Technical Director at Eaton Corp. He is a physicist with broad specialties in optics and lasers, holding multiple patents in assorted fields. Mr. Douglas-Hamilton has extensive experience in effectively managing large and small research and development projects.
Dean Gendron, Director, Member of Compensation Committee and Audit Committee - Mr. Gendron is the founder, President and CEO of Redan Capital Incorporated, a company that provides M&A, corporate finance and investment banking advisory services to early stage and developed private and public companies. Previously, Mr Gendron was Regional Manager of Solantus Inc. a non-traditional IT distribution company. Mr. Gendron serves as a director of Sintana Energy and previously served as a director of KCC Capital Corporation and Critical Outcome Technologies Inc., both TSX-V companies. Mr. Gendron is a director of Sintana Energy a TSX-V companies.
Bruno Maruzzo, Director and Chair of Audit Committee - Mr. Maruzzo is President of TechnoVenture Inc., a technology consulting company where he provides business development, corporate development, IR, engineering management and general management services to public and private high technology companies. Mr. Maruzzo is currently a director of Critical Outcome Technologies Inc., Sintana Energy, and Aim Explorations, all TSX V-listed companies.
Robert J. Potter, Director and Chair of Compensation Committee - Mr. Potter is Chief Executive Officer of SentryOne LLC, a performance optimization provider across the Microsoft platform. Formerly CEO-in-Residence at Alpine Investors.Prior to that he was Senior Vice President and General Manager, Business Information and Analytics of Rocket Software. and President and CEO of Expressor Software. Previously served with Sigma Partners, a leading venture group in Boston; President and CEO of Kalido Corporation; and Executive Vice President of Iona Technologie.
David Sable, Director - Dr. Sable is Portfolio Manager for the Special Situations Life Sciences Fund L.P. Previously, Dr. Sable was Director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey. He is board certified in both obstetrics and gynaecology and reproductive endocrinology, and has held academic positions at Harvard Medical School and the Columbia University Graduate School of Arts and Sciences. Dr. Sable served on the board of directors of RESOLVE: The National Infertility Society and is a member of the medical advisory board of Progyny. He is a graduate of the Wharton School and the University of Pennsylvania School of Medicine.
Daniel K. Thorne, Director and Member of Compensation Committee - Mr. Thorne is President of Star Lake Capital, Inc., a private venture capital firm that invests in technology companies, and its related fund, Star Lake Bioventures LLC. Mr. Thorne is also a Trustee Emeritus of the National Trust for Historic Preservation, Chairman of Global Heritage Fund, Vice President of the Harris and Eliza Kempner Fund, Chairman of the International Wildlife Trust, and a member of the board of trustees of Dian Fossey Gorilla Fund International.
David Wolf, Director, Chief Executive Officer and President- Previously, David was a member of the founding management team of Elcom International, Inc. (NASDAQ), playing a key role in growing the business to $800 million in revenues in 4 years and orchestrating Elcom's successful IPO. Prior to Elcom, David was COO of JWP Information Services, a subsidiary of JWP Inc. (NYSE) where he built the operational infrastructure to support its growth from $250 million to $1.4 billion in sales, and President and COO of NEECO, Inc. (NASDAQ), a $250 million business IT distribution and services business acquired by JWP. David has been involved in an operating or advisory role in over 40 M&A transactions.